{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:40:56Z","timestamp":1791330056397,"version":"4.3.1"},"reference-count":113,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013704","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["CONACYT PN-2017-01-5254"],"award-info":[{"award-number":["CONACYT PN-2017-01-5254"]}],"id":[{"id":"10.13039\/501100013704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa de Fortalecimiento de Institutos, Centros y Laboratorios de Investigaci\u00f3n 2021, Universidad de Guadalajara","award":["CONACYT PN-2017-01-5254"],"award-info":[{"award-number":["CONACYT PN-2017-01-5254"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Hepatitis B virus (HBV) is a challenge for global health services, affecting millions and leading thousands to end-stage liver disease each year. This comprehensive review explores the interactions between HBV and the host, examining their impact on clinical outcomes. HBV infection encompasses a spectrum of severity, ranging from acute hepatitis B to chronic hepatitis B, which can potentially progress to cirrhosis and hepatocellular carcinoma (HCC). Occult hepatitis B infection (OBI), characterized by low HBV DNA levels in hepatitis B surface antigen-negative individuals, can reactivate and cause acute hepatitis B. HBV genotyping has revealed unique geographical patterns and relationships with clinical outcomes. Moreover, single nucleotide polymorphisms (SNPs) within the human host genome have been linked to several clinical outcomes, including cirrhosis, HCC, OBI, hepatitis B reactivation, and spontaneous clearance. The immune response plays a key role in controlling HBV infection by eliminating infected cells and neutralizing HBV in the bloodstream. Furthermore, HBV can modulate host metabolic pathways involved in glucose and lipid metabolism and bile acid absorption, influencing disease progression. HBV clinical outcomes correlate with three levels of viral adaptation. In conclusion, the clinical outcomes of HBV infection could result from complex immune and metabolic interactions between the host and HBV. These outcomes can vary among populations and are influenced by HBV genotypes, host genetics, environmental factors, and lifestyle. Understanding the degrees of HBV adaptation is essential for developing region-specific control and prevention measures.<\/jats:p>","DOI":"10.3390\/pathogens12091146","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T07:52:11Z","timestamp":1694159531000},"page":"1146","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Host and HBV Interactions and Their Potential Impact on Clinical Outcomes"],"prefix":"10.3390","volume":"12","author":[{"given":"Alexis","family":"Jose-Abrego","sequence":"first","affiliation":[{"name":"Department of Genomic Medicine in Hepatology, Civil Hospital of Guadalajara, \u201cFray Antonio Alcalde\u201d, Guadalajara 44280, Mexico"},{"name":"Health Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-6634","authenticated-orcid":false,"given":"Sonia","family":"Roman","sequence":"additional","affiliation":[{"name":"Department of Genomic Medicine in Hepatology, Civil Hospital of Guadalajara, \u201cFray Antonio Alcalde\u201d, Guadalajara 44280, Mexico"},{"name":"Health Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-0920","authenticated-orcid":false,"given":"Saul","family":"Laguna-Meraz","sequence":"additional","affiliation":[{"name":"Department of Genomic Medicine in Hepatology, Civil Hospital of Guadalajara, \u201cFray Antonio Alcalde\u201d, Guadalajara 44280, Mexico"},{"name":"Health Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Panduro","sequence":"additional","affiliation":[{"name":"Department of Genomic Medicine in Hepatology, Civil Hospital of Guadalajara, \u201cFray Antonio Alcalde\u201d, Guadalajara 44280, Mexico"},{"name":"Health Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023, June 13). Hepatitis B, Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cld.2007.08.009","article-title":"Hepatitis B and end-stage liver disease","volume":"11","author":"Weisberg","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJM199312163292508","article-title":"Acute liver failure","volume":"329","author":"Lee","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/JCM.38.8.2975-2981.2000","article-title":"Molecular epidemiology of an outbreak of fulminant hepatitis B","volume":"38","author":"Petrosillo","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11908-019-0682-9","article-title":"Management of Fulminant Hepatitis B","volume":"21","author":"Ichai","year":"2019","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2014.04.036","article-title":"Occult hepatitis B infection","volume":"61","author":"Pollicino","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3851\/IMP2605","article-title":"Distribution of HBV genotypes F and H in Mexico and Central America","volume":"18","author":"Panduro","year":"2013","journal-title":"Antivir. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000360943","article-title":"Therapy of occult hepatitis B virus infection and prevention of reactivation","volume":"57","author":"Raimondo","year":"2014","journal-title":"Intervirology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1038\/s41598-023-32865-1","article-title":"Mapping hepatitis B virus genotypes on the African continent from 1997 to 2021: A systematic review with meta-analysis","volume":"13","author":"Kafeero","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1099\/0022-1317-69-10-2575","article-title":"Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes","volume":"69","author":"Okamoto","year":"1988","journal-title":"J. Gen. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1099\/0022-1317-73-5-1201","article-title":"Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains","volume":"73","author":"Norder","year":"1992","journal-title":"J. Gen. Virol."},{"key":"ref_15","first-page":"67","article-title":"A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness","volume":"81","author":"Stuyver","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1099\/0022-1317-83-8-2059","article-title":"Genotype H: A new Amerindian genotype of hepatitis B virus revealed in Central America","volume":"83","author":"Norder","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1099\/0022-1317-81-9-2267","article-title":"An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam","volume":"81","author":"Hannoun","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3201\/eid1411.080437","article-title":"Possible new hepatitis B virus genotype, southeast Asia","volume":"14","author":"Olinger","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1128\/JVI.00462-09","article-title":"A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J","volume":"83","author":"Tatematsu","year":"2009","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Velkov, S., Ott, J.J., Protzer, U., and Michler, T. (2018). The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. Genes, 9.","DOI":"10.3390\/genes9100495"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40506-016-0080-x","article-title":"Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy","volume":"8","author":"Osiowy","year":"2016","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3851\/IMP2599","article-title":"Distribution of HBV genotypes in Latin America","volume":"18","author":"Pinho","year":"2013","journal-title":"Antivir. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.3748\/wjg.v19.i33.5446","article-title":"HBV endemicity in Mexico is associated with HBV genotypes H and G","volume":"19","author":"Roman","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shah, A.A., Bodewes, R., Reijnen, L., Boelsums, T., Weller, C.M., Fanoy, E.B., and Veldhuijzen, I.K. (2021). Outbreaks of mumps genotype G viruses in the Netherlands between October 2019 and March 2020: Clusters associated with multiple introductions. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06702-7"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1180931","DOI":"10.3389\/fmicb.2023.1180931","article-title":"Tracing the evolutionary history of hepatitis B virus genotype H endemic to Mexico","volume":"14","author":"Roman","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e27941","DOI":"10.1097\/MD.0000000000027941","article-title":"Distribution of hepatitis B virus genotypes and subgenotypes: A meta-analysis","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jac\/dkn207","article-title":"Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir","volume":"62","author":"Bottecchia","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","article-title":"Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma","volume":"53","author":"Chan","year":"2004","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jpeds.2016.08.017","article-title":"Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis","volume":"178","author":"Gounder","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7883\/yoken.65.476","article-title":"Correlation between hepatitis B virus genotypes and clinical outcomes","volume":"65","author":"Shi","year":"2012","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_31","first-page":"1023","article-title":"High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico","volume":"11","author":"Roman","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Roca, T.P., Villar, L.M., Nogueira Lima, F.S., Vasconcelos, M.P.A., Borzacov, L.M.P., Silva, E.C.E., Lago, B.V.D., Silva, M., Botelho Souza, L.F., and Salcedo, J.M.V. (2022). Genomic Variability of Hepatitis B Virus Circulating in Brazilian Western Amazon. Viruses, 14.","DOI":"10.3390\/v14102100"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12985-015-0402-5","article-title":"Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia","volume":"12","author":"Payares","year":"2015","journal-title":"Virol. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12072-008-9115-9","article-title":"A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: A systematic review","volume":"3","author":"Roman","year":"2009","journal-title":"Hepatol. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jiac.2014.10.015","article-title":"An adolescent female having hepatocellular carcinoma associated with hepatitis B virus genotype H with a deletion mutation in the pre-S2 region","volume":"21","author":"Oba","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15467","DOI":"10.1128\/JVI.79.24.15467-15476.2005","article-title":"Recombination in the genesis and evolution of hepatitis B virus genotypes","volume":"79","author":"Simmonds","year":"2005","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21188","article-title":"Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam","volume":"43","author":"Toan","year":"2006","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2893.2012.01655.x","article-title":"New HBV subgenotype D9, a novel D\/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India","volume":"20","author":"Ghosh","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"640889","DOI":"10.3389\/fmicb.2021.640889","article-title":"Hepatitis B Virus (HBV) Genotype Mixtures, Viral Load, and Liver Damage in HBV Patients Co-infected With Human Immunodeficiency Virus","volume":"12","author":"Roman","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/jvh.12022","article-title":"Mechanism of the dependence of hepatitis B virus genotype G on co-infection with other genotypes for viral replication","volume":"20","author":"Sakamoto","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2893.2007.00931.x","article-title":"Susceptibility to active decompensated cirrhosis is associated with polymorphisms of intercellular adhesion molecule-1 (ICAM-1) in chronic HBV carriers","volume":"15","author":"Zhang","year":"2008","journal-title":"J. Viral. Hepat."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12935-015-0184-2","article-title":"Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population","volume":"15","author":"Sun","year":"2015","journal-title":"Cancer Cell Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3346\/jkms.2010.25.4.564","article-title":"Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriers","volume":"25","author":"Yu","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"ref_44","first-page":"185","article-title":"Associations between gene polymorphisms of signal transducer and activator of transcription 3 and the susceptibility to hepatitis B virus related liver cirrhosis","volume":"56","author":"Yan","year":"2022","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1038\/srep16278","article-title":"Genetic variations in STAT4, C2, HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinre.2018.12.005","article-title":"Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma","volume":"43","author":"Liu","year":"2019","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2147\/JHC.S321939","article-title":"A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis","volume":"8","author":"Mai","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zeisel, M.B., Guerrieri, F., and Levrero, M. (2021). Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081715"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.clinre.2013.09.002","article-title":"An X-chromosomal association study identifies a susceptibility locus at Xq22.1 for hepatitis B virus-related hepatocellular carcinoma","volume":"37","author":"Jiang","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e141965","DOI":"10.1172\/JCI141965","article-title":"SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection","volume":"131","author":"Tsai","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/carcin\/bgn090","article-title":"MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"29","author":"Yoon","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12985-017-0865-7","article-title":"Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: A case-control study","volume":"14","author":"Mardian","year":"2017","journal-title":"Virol. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e2987","DOI":"10.1002\/jgm.2987","article-title":"Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population","volume":"19","author":"Wang","year":"2017","journal-title":"J. Gene Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MCG.0000000000001520","article-title":"Hepatitis B Reactivation: A Review of Clinical Guidelines","volume":"55","author":"Wang","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"910549","DOI":"10.3389\/fmicb.2022.910549","article-title":"Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis with Acute Exacerbation","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jmv.25011","article-title":"Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents","volume":"90","author":"Matsuda","year":"2018","journal-title":"J. Med. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e3064","DOI":"10.1097\/MD.0000000000003064","article-title":"Human Cytokine Genetic Variants Associated with HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients","volume":"95","author":"Hsiao","year":"2016","journal-title":"Medicine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17634","DOI":"10.1038\/s41598-017-17959-x","article-title":"Effect of S267F variant of NTCP on the patients with chronic hepatitis B","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/infdis\/jis420","article-title":"Toll-like receptor and hepatitis B virus clearance in chronic infected patients: A long-term prospective cohort study in Taiwan","volume":"206","author":"Wu","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1002\/jmv.26969","article-title":"Polymorphisms of RIG-I-like receptor influence HBV clearance in Chinese Han population","volume":"93","author":"Yao","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/s41467-017-02304-7","article-title":"Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance","volume":"8","author":"Shen","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9069375","DOI":"10.1155\/2016\/9069375","article-title":"Clinical Relevance of HLA Gene Variants in HBV Infection","volume":"2016","author":"Wang","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/gutjnl-2015-310686","article-title":"The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B","volume":"65","author":"Hu","year":"2016","journal-title":"Gut"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5812\/hepatmon.94500","article-title":"Association of NTCP Gene Polymorphisms and Spontaneous Clearance of Hepatitis B Virus in Asia: A Meta-Analysis","volume":"19","author":"Hu","year":"2019","journal-title":"Hepat. Mon."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1128\/JVI.73.12.9710-9717.1999","article-title":"Integration of hepadnavirus DNA in infected liver: Evidence for a linear precursor","volume":"73","author":"Yang","year":"1999","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"104824","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential","volume":"180","author":"Xia","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1128\/JVI.77.13.7166-7173.2003","article-title":"Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein","volume":"77","author":"Kim","year":"2003","journal-title":"J. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1034968","DOI":"10.3389\/fimmu.2022.1034968","article-title":"Interferon and interferon-stimulated genes in HBV treatment","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.intimp.2012.03.018","article-title":"Identification of HLA-A*0201-restricted CD8+ T-cell epitope C64\u201372 from hepatitis B virus core protein","volume":"13","author":"Liu","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2893.2003.00486.x","article-title":"Expression of FasL and perforin\/granzyme B mRNA in chronic hepatitis B virus infection","volume":"11","author":"Lee","year":"2004","journal-title":"J. Viral. Hepat."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.omtm.2021.10.012","article-title":"Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors","volume":"23","author":"Schreiber","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Asao, H. (2021). Interleukin-21 in Viral Infections. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179521"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","article-title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_76","first-page":"1","article-title":"CDC guidance for evaluating healthcare personnel for hepatitis B virus protection and for administering postexposure management","volume":"62","author":"Schillie","year":"2013","journal-title":"MMWR Recomm. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations\u2014United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lin, S., and Zhang, Y.J. (2017). Interference of Apoptosis by Hepatitis B Virus. Viruses, 9.","DOI":"10.3390\/v9080230"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"27806","DOI":"10.1074\/jbc.M004449200","article-title":"Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression","volume":"275","author":"Ogden","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.3748\/wjg.v22.i36.8161","article-title":"Impact of hepatitis B virus infection on hepatic metabolic signaling pathway","volume":"22","author":"Shi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"23521","DOI":"10.1038\/srep23521","article-title":"HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1\/CDK2 signaling","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/cas.12461","article-title":"Long non-coding RNA UCA1 promotes glycolysis by up-regulating hexokinase 2 through the mTOR-STAT3\/microRNA143 pathway","volume":"105","author":"Li","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.metabol.2018.01.007","article-title":"A broad investigation of the HBV-mediated changes to primary hepatocyte physiology reveals HBV significantly alters metabolic pathways","volume":"83","author":"Lamontagne","year":"2018","journal-title":"Metabolism"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/15701646112099990008","article-title":"Role of HBV Replication in Host Cell Metabolism: A Proteomics Analysis","volume":"10","author":"Sadrolodabaee","year":"2013","journal-title":"Curr. Proteom."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"29872","DOI":"10.1074\/jbc.M111.259978","article-title":"Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase","volume":"286","author":"Shin","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1119(03)00586-9","article-title":"Glucose dependent [correction of dependant] negative translational control of the heterologous expression of the preS2 HBV antigen in yeast","volume":"311","author":"Gargouri","year":"2003","journal-title":"Gene"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e1980","DOI":"10.1038\/cddis.2015.322","article-title":"Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation","volume":"6","author":"Liu","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e0102022","DOI":"10.1128\/jvi.01020-22","article-title":"Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon\/cAMP\/Protein Kinase A\/CREB Signaling","volume":"96","author":"Chen","year":"2022","journal-title":"J. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/BJ20081336","article-title":"Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha","volume":"416","author":"Kim","year":"2008","journal-title":"Biochem. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes. Dev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","article-title":"SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond","volume":"43","author":"Ye","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wang, Y., Nakajima, T., Gonzalez, F.J., and Tanaka, N. (2020). PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062061"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1194\/jlr.R800079-JLR200","article-title":"Fatty acid metabolism: Target for metabolic syndrome","volume":"50","author":"Wakil","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Marechal, L., Laviolette, M., Rodrigue-Way, A., Sow, B., Brochu, M., Caron, V., and Tremblay, A. (2018). The CD36-PPARgamma Pathway in Metabolic Disorders. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051529"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1515\/hsz-2022-0345","article-title":"Interactions of Na(+)\/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: Novel potential targets for antiviral therapy","volume":"404","author":"Zakrzewicz","year":"2023","journal-title":"Biol. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41586-022-04857-0","article-title":"Structural insights into the HBV receptor and bile acid transporter NTCP","volume":"606","author":"Park","year":"2022","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/acs.jproteome.5b00217","article-title":"Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis","volume":"15","author":"Wang","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41423-023-01026-9","article-title":"Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma","volume":"20","author":"Xun","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.chom.2017.07.019","article-title":"Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses","volume":"22","author":"Lauber","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.abi5658","article-title":"Ten millennia of hepatitis B virus evolution","volume":"374","author":"Kocher","year":"2021","journal-title":"Science"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e2209613120","DOI":"10.1073\/pnas.2209613120","article-title":"The past 12,000 years of behavior, adaptation, population, and evolution shaped who we are today","volume":"120","author":"Larsen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.3748\/wjg.v20.i23.7181","article-title":"Hepatitis B virus infection in Latin America: A genomic medicine approach","volume":"20","author":"Roman","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1099\/jgv.0.001584","article-title":"SARS-CoV-2 one year on: Evidence for ongoing viral adaptation","volume":"102","author":"Peacock","year":"2021","journal-title":"J. Gen. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: The virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Tu, T., Budzinska, M.A., Shackel, N.A., and Urban, S. (2017). HBV DNA Integration: Molecular Mechanisms and Clinical Implications. Viruses, 9.","DOI":"10.3390\/v9040075"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/jmv.21846","article-title":"Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population","volume":"82","author":"Roman","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Jaramillo, C.M., de La Hoz, F., Porras, A., di Filippo, D., Choconta-Piraquive, L.A., Payares, E., Montes, N., and Navas, M.C. (2017). Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181643"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.4254\/wjh.v7.i30.2980","article-title":"Crosstalk between innate and adaptive immunity in hepatitis B virus infection","volume":"7","author":"Wang","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3748\/wjg.v20.i11.3044","article-title":"Acute hepatitis B of genotype H resulting in persistent infection","volume":"20","author":"Yamada","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_110","unstructured":"Centers for Disease Control and Prevention (2023, July 04). The Age-Adjusted Death Rate for Hepatitis C and Hepatitis B during 2020, Available online: https:\/\/www.cdc.gov\/hepatitis\/policy\/npr\/2022\/reduce-reported-hepatitis-b-deaths.htm#:~:text=The%20age%2Dadjusted%20hepatitis%20B,the%20target%20rate%20of%200.42."},{"key":"ref_111","unstructured":"Centers for Disease Control and Prevention (2023, July 04). Viral Hepatitis and Liver Cancer, Available online: https:\/\/www.cdc.gov\/nchhstp\/newsroom\/docs\/factsheets\/viral-hep-liver-cancer.pdf."},{"key":"ref_112","unstructured":"World Health Organization (2023, July 04). Guidelines on Hepatitis B and C Testing, Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241549981."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fmicb.2018.00854","article-title":"Evolutionary Analysis Provides Insight into the Origin and Adaptation of HCV","volume":"9","author":"Forni","year":"2018","journal-title":"Front. Microbiol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/9\/1146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:47:16Z","timestamp":1760129236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/9\/1146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":113,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["pathogens12091146"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12091146","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]}}}